"Carmat intends to sell the device to patients who are ineligible for transplants and who have no other possible treatments. It estimates that the device will eventually sell for 140,000 euros to 180,000 euros, or about $162,000 to $208,000."
http://www.nytimes.com/2015/01/20/business/international/carmat-artificial-heart.html?_r=1
lundi 19 janvier 2015
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire